Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability of Needle-free Injection for Fuzeon in HIV
NCT00233883Phase 4Completed
- Sponsor
- Roche
- Start
- Aug 2005
- Primary completion
- Jul 2006
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enfuvirtide in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Roche. Started Aug 2005; status: completed.
02
Drugs
enfuvirtide
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00233883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00233883.